Theravance Biopharma, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 44 | 0.0% | 2,330 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 39 | 0.0% | 2,662 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 29 | 0.0% | 2,661 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 24 | 0.0% | 2,661 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 323 | 0.0% | 34,333 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 278 | 0.0% | 34,503 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 301 | 0.0% | 35,548 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 345 | 0.0% | 38,454 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 521 | 0.0% | 46,384 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 483 | 0.0% | 56,016 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 673 | 0.0% | 65,010 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 745 | 0.0% | 68,664 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 851 | 0.0% | 75,859 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 756 | 0.0% | 74,534 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 683 | 0.0% | 75,342 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 699 | 0.0% | 73,158 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 874 | 0.0% | 79,054 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 558 | 0.0% | 75,440 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 1,067 | 0.0% | 73,457 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 1,436 | 0.0% | 70,341 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,254 | 0.0% | 70,553 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 1,028 | 0.0% | 69,547 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 1,456 | 0.0% | 69,351 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 1,723 | 0.0% | 74,542 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,784 | 0.0% | 68,906 | 12/31/2019 |